Side 1 fra 60 resultater
The present invention concerns the use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction, and pharmaceutical or dietetic compositions which contain such bacteria. The invention also concerns a strain of Lactobacillus brevis which is highly endowed
The present invention concerns the use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction, and pharmaceutical or dietetic compositions which contain such bacteria. The invention also concerns a strain of Lactobacillus brevis which is highly endowed
FIELD OF THE INVENTION
The present invention relates to new peptides and to use thereof, in particular for treatment and/or prevention of infections, inflammations and/or tumours.
BACKGROUND ART
Lactoferrin is a single chain metal-binding glycoprotein with a molecular weight of 77 kd. It has been
FIELD OF THE INVENTION
The present invention relates to new peptides and to use thereof, in particular for treatment and/or prevention of infections, inflammations and/or tumours.
BACKGROUND ART
Lactoferrin is a single chain metal-binding glycoprotein with a molecular weight of 77 kd. It has been
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to an arginine silicate inositol complex and its use in the prevention and treatment of a variety of disease states and disorders.
2. Description of the Related Art
Until recently, infectious disease had been the
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to cosmetic and human and animal health compositions, and, more particularly, to the reaction product of arginine and p-aminobenzoic acid (PABA), and compositions thereof, useful for treating wounds, lesions, burns,
SEQUENCE STATEMENT
Incorporated by reference herein in its entirety is the Sequence Listing entitled "G18U10C0390PUS_ST25," created Oct. 29, 2018, size of 5 kilobyte.
BACKGROUND
1. Field of the Invention
The prevent invention relates to a gene/carrier complex for preventing or treating inflammatory
1. INTRODUCTION
This invention concerns new methods and compositions that are useful in treating inflammatory conditions, e.g., preventing and ameliorating cachexia, the clinical syndrome of poor nutritional status and bodily wasting associated with cancer and other chronic diseases. More
1. INTRODUCTION
This invention concerns new methods and compositions that are useful in treating inflammatory conditions, e.g., preventing and ameliorating cachexia, the clinical syndrome of poor nutritional status and bodily wasting associated with cancer and other chronic diseases. More
TABLE OF CONTENTS
1. INTRODUCTION
2. BACKGROUND OF THE INVENTION
2.1. THE SIGNS OF CACHEXIA ARE DISTINCT FROM THOSE OF STARVATION
2.2. THE IMPLICATIONS OF THE DIFFERENCES BETWEEN CACHEXIA AND STARVATION
2.3. THE IMPACT OF THE ROLE OF CYTOKINES INCACHEXIA ON THE SEARCH FOR THERAPIES
2.4. NITRIC OXIDE
1. INTRODUCTION
This invention concerns new methods and compositions that are useful in treating inflammatory conditions, e.g., preventing and ameliorating cachexia, the clinical syndrome of poor nutritional status and bodily wasting associated with cancer and other chronic diseases. More
1. INTRODUCTION
2. BACKGROUND OF THE INVENTION
2.1. THE SIGNS OF CACHEXIA ARE DISTINCT FROM THOSE OF STARVATION
2.2. THE IMPLICATIONS OF THE DIFFERENCES BETWEEN CACHEXIA AND STARVATION
2.3. THE IMPACT OF THE ROLE OF CYTOKINES INCACHEXIA ON THE SEARCH FOR THERAPIES
2.4. NITRIC OXIDE AS A MEDIATOR OF
1. INTRODUCTION
This invent concerns new methods and compositions that are useful in treating inflammatory conditions, e.g., preventing and ameliorating cachexia, the clinical syndrome of poor nutritional status and bodily wasting associated with cancer and other chronic diseases. More particularly,
1. INTRODUCTION
This invention concerns new methods and compositions that are useful in treating inflammatory conditions, e.g., preventing and ameliorating cachexia, the clinical syndrome of poor nutritional status and bodily wasting associated with cancer and other chronic diseases. More
1. INTRODUCTION
This invention concerns new methods and compositions that are useful in treating inflammatory conditions, e.g., preventing and ameliorating cachexia, the clinical syndrome of poor nutritional status and bodily wasting associated with cancer and other chronic diseases. More